Literature DB >> 12633080

Chiral-auxiliary-controlled diastereoselectivity in the epoxidation of enecarbamates with DMD and mCPBA.

Waldemar Adam1, Sara G Bosio, Barbara T Wolff.   

Abstract

[structure: see text] Chiral oxazolidinone-substituted enecarbamates 1 are epoxidized in a diastereoselectivity up to 93:7 for both DMD and mCPBA. The diastereofacial differentiation depends on the steric interaction between the R(1) substituent on the oxazolidinone ring and the incoming electrophile. The stereochemical course of epoxidation was assessed by chemical correlation with the known optically active diols.

Entities:  

Year:  2003        PMID: 12633080     DOI: 10.1021/ol0273194

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  A tandem 1,3-H-shift-6π-electrocyclization-cyclic 2-amido-diene intramolecular Diels-Alder cycloaddition approach to BCD-Ring of atropurpuran.

Authors:  Ryuji Hayashi; Zhi-Xiong Ma; Richard P Hsung
Journal:  Org Lett       Date:  2011-12-13       Impact factor: 6.005

2.  A stereoselective intramolecular halo-etherification of chiral enamides in the synthesis of halogenated cyclic ethers.

Authors:  Changhong Ko; Richard P Hsung; Ziyad F Al-Rashid; John B Feltenberger; Ting Lu; Jin-Haek Yang; Yonggang Wei; Craig A Zificsak
Journal:  Org Lett       Date:  2007-10-02       Impact factor: 6.005

3.  A highly regio- and stereoselective synthesis of α-fluorinated imides via fluorination of chiral enamides.

Authors:  Yan-Shuang Xu; Yu Tang; He-Jing Feng; Ji-Tian Liu; Richard P Hsung
Journal:  Org Lett       Date:  2015-01-12       Impact factor: 6.005

4.  Synthesis of amido-spiro[2.2]pentanes via Simmons-Smith cyclopropanation of allenamides.

Authors:  Ting Lu; Ryuji Hayashi; Richard P Hsung; Kyle A DeKorver; Andrew G Lohse; Zhenlei Song; Yu Tang
Journal:  Org Biomol Chem       Date:  2009-06-19       Impact factor: 3.876

5.  Cyclization reactions through DDQ-mediated vinyl oxazolidinone oxidation.

Authors:  Lei Liu; Paul E Floreancig
Journal:  Org Lett       Date:  2009-07-16       Impact factor: 6.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.